Nuveen Asset Management, LLC Aerovate Therapeutics, Inc. Transaction History
Nuveen Asset Management, LLC
- $340 Billion
- Q4 2024
A detailed history of Nuveen Asset Management, LLC transactions in Aerovate Therapeutics, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 40,047 shares of AVTE stock, worth $107,325. This represents 0.0% of its overall portfolio holdings.
Number of Shares
40,047
Previous 40,047
-0.0%
Holding current value
$107,325
Previous $83,000
27.71%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding AVTE
# of Institutions
12Shares Held
4.48MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY983KShares$2.63 Million0.0% of portfolio
-
Oup Management Co., LLC604KShares$1.62 Million18.43% of portfolio
-
Jpmorgan Chase & CO New York, NY75.7KShares$202,8060.0% of portfolio
-
Kovitz Investment Group Partners, LLC24.2KShares$64,8820.0% of portfolio
-
Alamea Verwaltungs Gmb H Edison, NJ204Shares$5460.0% of portfolio
About Aerovate Therapeutics, Inc.
- Ticker AVTE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,448,100
- Market Cap $65.5M
- Description
- Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. The company focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which ...